Tag: neurorehabilitation
MindMaze launches Izar neurological rehabilitation device in USA and Europe
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked...
Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses...
Neurofenix completes US$7 million Series A funding for digital stroke and...
Neurofenix has raised US$7 million in Series A funding via a round led by AlbionVC, with additional participation from HTH, InHealth Ventures, and existing...
Randomised data support use of tDCS in Parkinson’s patients with Pisa...
Data from a randomised controlled trial (RCT), which have been published in Frontiers in Neurology, support the use of neuromodulation with transcranial direct current...
